Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C063609 |
1,2-dimethyl-4-nitrobenzene |
1,2-dimethyl-4-nitrobenzene results in decreased expression of TGM1 mRNA | decreases expression | 19784758
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of TGM1 mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of TGM1 mRNA | increases expression | 18648102
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of TGM1 mRNA | affects expression | 21346803
|
C002202 |
4-oxoretinoic acid |
4-oxoretinoic acid results in decreased expression of TGM1 mRNA | decreases expression | 15982314
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of TGM1 mRNA | affects expression | 17562736
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of TGM1 mRNA | affects expression | 19784758
|
D000082 |
Acetaminophen |
Acetaminophen results in decreased expression of TGM1 mRNA | decreases expression | 19784758
|
D000082 |
Acetaminophen |
Acetaminophen results in increased expression of TGM1 mRNA | increases expression | 19784758
|
C103303 |
alitretinoin |
alitretinoin results in decreased expression of TGM1 mRNA | decreases expression | 15982314
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of TGM1 mRNA | affects expression | 16483693
|
C015001 |
arsenite |
arsenite results in decreased expression of TGM1 mRNA | decreases expression | 18929588
|
C015001 |
arsenite |
TRP53 protein affects the reaction [arsenite results in decreased expression of TGM1 mRNA] | affects reaction|decreases expression | 18929588
|
D002118 |
Calcium |
Calcium results in increased expression of TGM1 mRNA | increases expression | 10469331
|
D002118 |
Calcium |
NPS R-467 promotes the reaction [Calcium results in increased expression of TGM1 mRNA] | increases expression|increases reaction | 10469331
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased expression of TGM1 mRNA | decreases expression | 19784758
|
D002117 |
Calcitriol |
Calcitriol results in decreased expression of TGM1 mRNA | decreases expression | 16002434
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of TGM1 mRNA | increases expression | 18035473
|
D006854 |
Hydrocortisone |
[Hydrocortisone co-treated with sodium arsenate] results in increased expression of TGM1 mRNA | affects cotreatment|increases expression | 11485391
|
D006854 |
Hydrocortisone |
[Hydrocortisone co-treated with sodium arsenite] results in increased expression of TGM1 mRNA | affects cotreatment|increases expression | 11485391
|
D006854 |
Hydrocortisone |
Hydrocortisone results in increased expression of TGM1 mRNA | increases expression | 11485391
|
D006854 |
Hydrocortisone |
sodium arsenate inhibits the reaction [Hydrocortisone results in increased expression of TGM1 mRNA] | decreases reaction|increases expression | 11485391
|
D006854 |
Hydrocortisone |
sodium arsenite inhibits the reaction [Hydrocortisone results in increased expression of TGM1 mRNA] | decreases reaction|increases expression | 11485391
|
D008743 |
Methyl Parathion |
Methyl Parathion results in decreased expression of TGM1 mRNA | decreases expression | 19784758
|
D009578 |
Nitrobenzenes |
Nitrobenzenes analog results in decreased expression of TGM1 mRNA | decreases expression | 19784758
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of TGM1 mRNA | increases expression | 17616710
|
C111654 |
NPS R-467 |
NPS R-467 promotes the reaction [Calcium results in increased expression of TGM1 mRNA] | increases expression|increases reaction | 10469331
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in increased expression of TGM1 mRNA] | affects reaction|increases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in decreased expression of TGM1 mRNA | decreases expression | 19482888
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of TGM1 mRNA] | decreases reaction|increases expression | 16985168
|
C059514 |
resveratrol |
resveratrol results in increased expression of TGM1 mRNA | increases expression | 16985168
|
D015474 |
Isotretinoin |
Isotretinoin results in decreased expression of TGM1 mRNA | decreases expression | 15982314
|
C009277 |
sodium arsenate |
[Hydrocortisone co-treated with sodium arsenate] results in increased expression of TGM1 mRNA | affects cotreatment|increases expression | 11485391
|
C009277 |
sodium arsenate |
sodium arsenate inhibits the reaction [Hydrocortisone results in increased expression of TGM1 mRNA] | decreases reaction|increases expression | 11485391
|
C009277 |
sodium arsenate |
sodium arsenate results in decreased expression of TGM1 mRNA | decreases expression | 11485391
|
C017947 |
sodium arsenite |
[Hydrocortisone co-treated with sodium arsenite] results in increased expression of TGM1 mRNA | affects cotreatment|increases expression | 11485391
|
C017947 |
sodium arsenite |
sodium arsenite inhibits the reaction [Hydrocortisone results in increased expression of TGM1 mRNA] | decreases reaction|increases expression | 11485391
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of TGM1 mRNA | decreases expression | 11485391
|
D013749 |
Tetrachlorodibenzodioxin |
resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of TGM1 mRNA] | decreases reaction|increases expression | 16985168
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of TGM1 mRNA | increases expression | 16985168
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of TGM1 protein | increases expression | 16985168
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of TGM1 mRNA | increases expression | 16960034
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of TGM1 mRNA | increases expression | 16960034
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased expression of TGM1 mRNA | increases expression | 11485391
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased expression of TGM1 mRNA | increases expression | 10866668
|
D013853 |
Thioacetamide |
Thioacetamide results in decreased expression of TGM1 mRNA | decreases expression | 19784758
|
D014212 |
Tretinoin |
Tretinoin metabolite results in decreased expression of TGM1 mRNA | decreases expression | 15982314
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of TGM1 mRNA | decreases expression | 16985168 15982314 17147502
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
18.51 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Isotretinoin |
18.51 | 18769834 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
18.51 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
18.51 | 11752688 14514962 15322242 |
MESH:D000015 |
Abnormalities, Multiple |
|
Isotretinoin |
4.77 | 18769834 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.33 | 18287403 |
MESH:D017486 |
Acneiform Eruptions |
|
Isotretinoin |
6.05 | 16232082 |
MESH:D000152 |
Acne Vulgaris |
|
Isotretinoin |
5.25 | 16185265 18769834 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.65 | 16538975 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
6.40 | 3712494 |
MESH:D000236 |
Adenoma |
|
resveratrol |
6.40 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
9.32 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.32 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.47 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.67 | 17306315 16712894 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.44 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.52 | 16162502 16183991 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.75 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.61 | 10982225 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
7.05 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.05 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.21 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.28 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.14 | 17967414 16873680 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.44 | 18445737 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.18 | 16935849 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.79 | 11289319 1440618 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
14.22 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Thioacetamide |
14.22 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
14.22 | 16197459 16206674 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.56 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.62 | 15746008 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.06 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
2.28 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.28 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.28 | 16393696 17534123 17651959 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.28 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.28 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.36 | 16813970 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.56 | 16050911 16011737 15721981 16124888 3786805 16097048 10355542 15673190 16227642 18705752 16192424 15700767 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.62 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.93 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
19.16 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
19.16 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
19.16 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
19.16 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
19.16 | 20007298 20935162 6705139 17173139 1701930 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
19.16 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
19.16 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Thioacetamide |
19.16 | 17997003 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
19.16 | 1917145 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.36 | 16675471 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.57 | 7296757 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
17.21 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Isotretinoin |
17.21 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
17.21 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
17.21 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
17.21 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
17.21 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.24 | 18670907 16120746 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.32 | 15458977 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
11.61 | 14694615 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
11.61 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
11.61 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
6.22 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
6.22 | 20056578 19524636 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.03 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.36 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.91 | 16835633 |
MESH:D018281 |
Cholangiocarcinoma |
|
Thioacetamide |
8.91 | 18291259 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
2.98 | 9022650 19486331 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.93 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Hydrocortisone |
9.42 | 15826874 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
9.42 | 8697196 15340226 16354765 15668235 12621046 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
9.42 | 9407595 |
MESH:D003092 |
Colitis |
|
resveratrol |
8.88 | 16474422 |
MESH:D003092 |
Colitis |
|
Tretinoin |
8.88 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
3.90 | 15037631 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
3.90 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.22 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
8.55 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
8.55 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.61 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Hydrocortisone |
7.10 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Isotretinoin |
7.10 | 18769834 9879862 |
MESH:D019465 |
Craniofacial Abnormalities |
|
sodium arsenate |
7.10 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
7.10 | 15322242 20055451 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
7.10 | 17551590 9125849 10589399 16925845 8800419 9224671 9142499 9211117 14991402 9664655 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
3.79 | 18551238 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.59 | 11298694 18759878 8970840 11906362 2524372 8156756 14531868 12868966 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.28 | 3621924 2952479 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.59 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.61 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
3.77 | 16286809 |
MESH:D003967 |
Diarrhea |
|
Hydrocortisone |
4.50 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
21.03 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
21.03 | 6679447 9328219 16192314 9022650 7440962 9653073 18692083 18289764 6482804 18648102 11289319 8291058 1440618 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
21.03 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
21.03 | 11287661 16781746 19416960 10663392 16109766 18713872 2444490 12540782 11834606 14725611 16227642 11743745 16393943 11529661 16485898 14550746 17562736 12153990 16081117 11739529 19085960 19739265 19923254 19420014 10915739 12705907 14986274 12958197 10774834 15619225 15968718 16177239 17522070 12392966 11421492 19164858 19370779 18071297 11461765 17906064 12594235 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
21.03 | 3786805 10915739 3732212 6884620 4309450 10092053 9327722 15027814 19336974 21278145 6623471 2869522 15968718 7179309 17522070 19085960 7120509 16227642 11566570 16177239 15998439 7440962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
sodium arsenate |
21.03 | 18186108 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
21.03 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Thioacetamide |
21.03 | 12963478 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.87 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.59 | 11462148 |
MESH:D015352 |
Dry Eye Syndromes |
marker/mechanism |
|
| 16146918 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.79 | 1851702 |
MESH:D004487 |
Edema |
|
resveratrol |
10.41 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
10.41 | 11000095 12711302 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
10.41 | 8273558 16716910 15177302 11698051 9599246 8113982 7812673 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.17 | 16714409 18230668 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.17 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
8.67 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
8.67 | 17872969 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
2.96 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.82 | 9294722 10568697 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.62 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.88 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.64 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.77 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.35 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.03 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.79 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.44 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
4.44 | 15623463 16805852 15264214 15150132 16510608 15547733 16704527 15547721 15878914 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.28 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.28 | 9664655 16938888 |
MESH:D005218 |
Fat Necrosis |
|
Thioacetamide |
5.49 | 16456712 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
7.37 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
7.37 | 16239168 16045604 19224547 12795759 17595544 61145 15959796 12631006 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.23 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.79 | 6705139 |
MESH:D005355 |
Fibrosis |
|
arsenite |
19.32 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
19.32 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
19.32 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
19.32 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.44 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.45 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.86 | 17312396 |
MESH:D018149 |
Glucose Intolerance |
|
sodium arsenate |
4.87 | 19446573 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.82 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.36 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.03 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.93 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.14 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.14 | 14991402 9664655 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.13 | 11000095 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Thioacetamide |
4.37 | 15929193 18665440 17276928 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
14.45 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
14.45 | 19110552 19900420 |
MESH:D006505 |
Hepatitis |
|
Thioacetamide |
14.45 | 16456712 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
7.70 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.70 | 16120746 15340226 12621046 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.95 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.97 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.81 | 16354765 18606429 16959395 15340226 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.03 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.03 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.30 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.80 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.34 | 16778211 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.82 | 16873680 |
MESH:D006962 |
Hyperparathyroidism, Secondary |
|
NPS R-467 |
6.85 | 15086907 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.71 | 15034207 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.82 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.86 | 15338365 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.10 | 17488730 |
OMIM:242100 |
ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL, NONBULLOUS, 1 |
marker/mechanism |
|
| |
MESH:D017490 |
Ichthyosis, Lamellar |
marker/mechanism |
|
| |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.42 | 17600658 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.84 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
11.04 | 17296493 |
MESH:D007249 |
Inflammation |
|
resveratrol |
11.04 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
11.04 | 12200463 12878042 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
11.04 | 15177302 7562506 11698051 8273558 7812673 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.31 | 16624496 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.54 | 17994277 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.79 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.25 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.25 | 15992940 17551590 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.41 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.53 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
5.53 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
6.75 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.75 | 6582329 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.81 | 16316344 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.66 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.49 | 16932348 19285840 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.04 | 16294345 19850784 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
7.28 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.28 | 9834237 16891316 17217047 17301526 17107899 16935935 17368321 19029980 19035177 17361223 16766008 19225113 16140955 12679006 16788101 17506722 17339181 19075265 17649720 19642359 17294898 15748426 16331271 17712046 16823087 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.15 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
10.38 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
10.38 | 16221502 17157831 21278145 11903743 16239168 11408273 17174718 16943688 17334410 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
10.38 | 21047994 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.06 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
4.73 | 16248980 16097048 15876570 15362042 17714472 17900296 18412020 12741479 17922224 17640975 17761835 17869086 18210741 14716833 15338365 12445421 18395914 12649538 12546737 14724832 17557913 15893842 17805973 18420326 15730626 17525996 12958196 10355542 17766677 15650968 13678700 20821823 12632514 12609069 17708605 18395095 12632512 12666154 16192424 12667390 15673190 17976157 17631135 15370692 18251166 18279442 15818738 15925388 12898905 18705752 18376398 18429990 18187930 11481614 18418968 12586293 16011737 18481824 14620537 14512876 18472332 16638106 15057751 16136751 18166357 15959796 12389079 18156304 16116963 17721639 18277467 12445418 16027843 17944888 18006644 16015684 18472094 18054572 15996030 17823541 17565644 15052691 15931870 14716496 18317297 17698563 18205269 17481882 18263696 15123356 18339082 14748882 16033810 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.73 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Thioacetamide |
4.73 | 15288472 11481614 15158331 12175628 16248980 16511523 18458672 16126171 18031379 18416461 17292413 15316131 10677585 15334695 16097051 18395095 18295389 15362042 16343077 15465738 18380797 11172339 15716488 17629604 17355460 18606216 15095483 12085344 18032466 18615449 12557150 12531686 14739098 15474484 15288473 15075984 17127702 16489207 11682029 12679928 16098781 17050028 12891558 15078482 18263696 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
4.73 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
marker/mechanism |
|
| 19784758 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
8.89 | 11587558 12969438 16610002 19014921 12587719 19784758 19460945 16611625 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
8.89 | 17285989 16964402 15720792 16246199 15830285 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
8.89 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
Thioacetamide |
8.89 | 18374380 15158337 16337175 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.94 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
15.10 | 17185352 16871587 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
15.10 | 16899240 14706259 |
MESH:D017114 |
Liver Failure, Acute |
|
Thioacetamide |
15.10 | 12479984 15313186 17276928 15633222 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
13.31 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
13.31 | 19073162 15975961 19482888 19812893 21047994 8742319 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
13.31 | 19073162 20405173 19812893 19321006 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
13.31 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
13.31 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
12.94 | 3712494 1399818 6587162 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
12.94 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
12.94 | 1399818 6150874 2563599 17172636 18308698 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
12.94 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.02 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
8.19 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
8.19 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Isotretinoin |
8.19 | 15899809 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
8.19 | 15276417 19931552 17077188 17306315 16712894 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
8.19 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
8.19 | 11807781 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.09 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.69 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.02 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
5.96 | 8985016 11606380 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
5.96 | 8985016 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.70 | 17453147 |
MESH:D008545 |
Melanoma |
|
Isotretinoin |
7.01 | 17237267 |
MESH:D008545 |
Melanoma |
|
resveratrol |
7.01 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
7.01 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
7.01 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.34 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.20 | 16940565 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.17 | 17112576 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.31 | 17049120 16490592 14749477 17164350 17935668 16267019 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.64 | 17962980 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
sodium arsenate |
4.65 | 18186108 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
2.95 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
2.94 | 17188708 16317513 17125593 17015251 16525036 16456233 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.41 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.41 | 12213967 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.53 | 17322642 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.25 | 17484760 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.63 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.38 | 3581430 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
7.76 | 16946489 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
7.76 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
7.76 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
8.48 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
8.48 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
4.18 | 15738583 |
MESH:D009397 |
Nephrocalcinosis |
|
NPS R-467 |
6.85 | 15086907 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.78 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
8.78 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
16.16 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenate |
16.16 | 11749123 10525206 19446573 18186108 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
16.16 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
16.16 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Isotretinoin |
3.93 | 17368321 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
7.74 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
7.74 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.19 | 17929310 |
MESH:D020258 |
Neurotoxicity Syndromes |
marker/mechanism |
|
| 19784758 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Methyl Parathion |
4.69 | 19784758 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
14.01 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
14.01 | 6482804 4026338 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
14.01 | 14694615 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.79 | 3988306 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.13 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.64 | 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.04 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.64 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
4.64 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
5.98 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
5.98 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
8.22 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
8.22 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
8.22 | 15976015 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
8.65 | 7296757 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
8.65 | 8330346 12065085 18404319 18922899 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.02 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.24 | 6228378 |
MESH:D011041 |
Poisoning |
|
Methyl Parathion |
4.83 | 17603234 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
5.77 | 16144296 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.34 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
3.43 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Isotretinoin |
15.09 | 18769834 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
15.09 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
15.09 | 11222880 11896295 11118676 11399792 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.55 | 15572423 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.74 | 16289102 15754350 16644109 18247401 12479363 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.74 | 17636462 17675339 17804756 16731767 17718901 15767336 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.74 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.39 | 16636307 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.26 | 12752131 |
MESH:D011596 |
Psychomotor Disorders |
|
Isotretinoin |
5.69 | 18769834 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.56 | 16723453 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.35 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
3.16 | 17058453 16314181 16317513 17520802 15827377 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.21 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.89 | 16116481 16283617 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.42 | 18551238 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
5.42 | 3137016 11442880 4039156 16876388 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.59 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
16.80 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
16.80 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
16.80 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
16.80 | 8330346 18404319 8985016 12065085 11807781 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
16.80 | 16467112 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.62 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
2.57 | 12958204 17575124 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.57 | 17261132 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.28 | 16321402 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.67 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
10.97 | 3712494 7505956 6587162 6582329 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
10.97 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
10.97 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
9.25 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
9.25 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.09 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
7.78 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.78 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
7.78 | 16452187 11723127 17306315 16712894 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.09 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.77 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
14.74 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
14.74 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
14.74 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
3.92 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.38 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.20 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.36 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.08 | 17488730 |
MESH:D014802 |
Vitamin A Deficiency |
marker/mechanism |
|
| 16146918 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.84 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.02 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.78 | 16287080 |